Awards for April, May, and June 2014

Federal Awards

Abbara, Suhny, Massachusetts Genl Hosp/NIH, Inflammatory Mechanisms and Treatment Strategies for Atherosclerosis in HIV, $9,677; Ahmad, Zahid, NIH, Molecular Basis of Autosomal Dominant Hypercholesterolemia in a Multiethnic Cohort, $155,250; Alto, Neal, NIH, Type III Effector Regulation of Host GTPase Signaling, $451,609; Alto, Neal (Fellow A. Jimenez), Natl Science Fdn, Graduate Research Fellowship Program, $44,000; Ariizumi, Kiyoshi, NIH, DC-HIL in Cutaneous Immunity, $39,352; Attanasio, Massimo, NIH, Role of GLIS2 in Development of Cystic Kidney Disease, $345,825; Badawy, Mohamed, Med College of Wisconsin/NIH, Use of Mechanism of Injury for the Identification of Severely Injured Children, $95,284; Beutler, Bruce, NIH, Genetic Analysis of Resistance to Viral Infection, $2,627,681; Bezprozvanny, Ilya, NIH, Presenilins and Neuronal Calcium Dyshomeostasis, $454,522; Bibb, James, NIH, Role of Cdk5 in Stroke, $344,335; Bibb, James, NIH, NMDA Receptor Regulation in Addiction, $318,000;

Bobulescu, Ion, NIH, Protein Phosphatase Regulation of Principal Renal Sodium Transporter NHE3, $86,847; Boothman, David, NIH, Use of Beta-lapachone for Lung Cancer Chemotherapy, $325,086; Boothman, David, NIH, Ku70 Binding Protein-5 (KUB5), Novel Factor in Nonhomologous End Joining, $310,426; Boothman, David, NIH, Ku70 Binding Protein-5 (KUB5), Novel Factor in Nonhomologous End Joining - Diversity Suppl, $93,209; Brekken, Rolf, NIH, Axl as Target for Therapy of Pancreatic Cancer, $12,104; Brekken, Rolf (Fellow K. Aguilera), NIH, SPARC as Regulator of Collagen Signaling in Pancreatic Cancer - Diversity Fellowship, $444; Brown, Kathlynn, NIH, Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer, $320,027; Brown, Sherwood, NIH, Antidepressant Treatment at Inner City Asthma Clinic, $107,565; Burma, Sandeep, NASA, Mouse Glioma Models to Estimate Cancer Risks from HZE Particle Exposure, $449,299; Burma, Sandeep, NIH, Molecular Mechanisms of GBM Radioresistance and Strategies for Radiosensitization, $23,094;

Burstein, Ezra, NIH, Gastroenterology/Hepatology Research Training Program, $227,892; Cannon, Stephen, NIH, Disease Pathogenesis and Modification for CaV1.1-Associated Hypokalemic Periodic Paralysis, $369,222; Cao, Dian, NIH, Autophagy in Metabolic Distress and Cardiac Function: Regulation by the HDAC-FoxO, $132,285; Carroll, Thomas, NIH, UTSW Summer Undergraduate Research Institute for the Study of Kidney Diseases, $100,764; Castrillon, Diego, NIH, Mouse Models and Translational Studies of Endometrial Cancer, $22,402; Chen, Benjamin, NIH, DNA-PKcs Phosphorylation on Hematopoietic Stem Cells Genome Maintenance, $320,027; Chen, Chuo, NIH, Identifying Molecular Targets and Biological Signatures of CAM Natural Products, $431,984; Chen, Zhijian, NIH, Mechanisms of Protein Kinase Activation by Ubiquitin in NF-kB Pathways, $11,965; Chong, Benjamin, NIH, Molecular Markers in Discoid Lupus Erythematous, $123,012;

Cobb, Melanie, NIH, Insulin-Regulated MAP Kinase Pathways, $497,201; Cobb, Melanie, NIH, Cell & Molecular Biology Training Program, $422,423; Conrad, Nicholas, NIH, Mechanisms of KSHV Post-Transcriptional Gene Regulation, $314,820; Conrad, Nicholas, NIH, Mechanisms of KSHV Post-Transcriptional Gene Regulation - Diversity Suppl, $15,424; Corey, David, NIH, Mechanism of RNA-Mediated Control of Transcription of Splicing, $286,200; Crandall, Craig, NIH, Exercise in Burn Survivors, $526,427; Crandall, Craig, US Dept of Defense, Effects of Thermal Status on Markers of Blood Coagulation during Simulated Hemorrhage, $306,538; Crandall, Craig (Fellow Z. Schlader), NIH, Cognitive Function, Hyperthermia, and Aging, $53,282; Deberardinis, Ralph, NIH, Metabolic Regulators of Tumor Cell Growth, $320,027; Deberardinis, Ralph, Univ of Cincinnati/NIH, Metabolic Adaptive Responses in Cancer, $13,699;

Eisch, Amelia, NIH, Basic Science Training Program in Drug Abuse, $350,140; Eisch, Amelia, NASA, Molecular and Cellular Mechanisms of Space Radiation-Induced Changes in Hippocampal-Dependent Behavior, $290,016; Elmquist, Joel, NIH, Leptin Action and Central Melanocortin Systems - Diversity Suppl, $89,040; Farrar, John, NIH, Type 1 Interferon-Regulated T Helper Development, $41,965; Flores, Glenn, NIH, Randomized Trial of Effects of Parent Mentors on Insuring Minority Children, $529,338; Garcia, Joseph, NIH, Molecular Mechanisms Dictating Sirt1/HIF-2 Signaling During Hypoxia, $332,955; Gardner, Kevin, NIH, Mechanistic Principles of Signal Detection and Transmission in Bacterial Two-Component Systems, $325,438; Gardner, Kevin, NIH, Molecular Biophysics Predoctoral Training Program, $132,119; Getachew, Yonas, NIH, Drug Induced Hepatotoxcity During Viral Hepatitis, $142,668; Ghose, Subroto, NIH, Synaptic Plasticity in Adolescent Cannabis Users: Relevance to Schizophrenia, $388,327;

Goldberg, Mark, NIH, Network of Excellence in Neuroscience Clinical Trials (NEXT), $308,798; Goldsmith, Elizabeth, NIH, Chloride Sensing by WNK Kinases, $278,250; Goldstein, Joseph, NIH, Molecular Basis of Cholesterol Metabolism, $4,197,287; Goodman, Joel, NIH, Simple Cellular Model for Lipodystrophy, $318,000; Graff, Jonathan, NIH, Invertebrate Models of Fat Storage, $368,072; Graves, Donna, Massachusetts Genl Hosp/NIH, Study of Ibudilast (MN-166) in Subjects with Progressive Multiple Sclerosis, $4,125; Green, Carla (Fellow C. Rosenweig), NIH, Investigation of the Spontaneous Circadian Hamster Mutation Theta, $30,368; Greenberg, David, NIH, Novel Gene-Silencing Therapeutics for Multidrug-Resistant Gram-Negative Pathogens, $372,084; Greilich, Philip, New England Research Insts/NIH, Transfusion Medicine/Hemostasis Clinical Trials Network (TMH), $12,660; Gruchalla, Rebecca, Univ of Wisconsin/NIH, Inner City Asthma Consortium (ICAC): Registry for Asthma Characterization and Recruitment (RACR) Supplement, $56,008;

Halm, Ethan, Northern California Inst/NIH, Comparative Effectiveness of Carotid Artery Revascularization vs. Medical Therapy, $16,715; Hansen, Eric, NIH, Haemophilus Ducreyi Inhibits Phagocytosis, $39,750; He, Yu-Guang, Vital Art and Science/NIH, Home-Based DR Vision Diagnostic System; SIBR Phase 2, $73,366; Hendrixson, David, NIH, Campylobacter Jejuni Flagellar Regulation and Synthesis, $397,500; Hendrixson, David, NIH, Structural Components of Campylobacter jejuni Polar Flagellar Motor, $13,911; Hiesinger, Robin, NIH, Drosophila Model for Charcot-Marie-Tooth 2B Disease, $311,640; Hiesinger, Robin (Fellow E. Jin), NIH, Endolysosomal Function in Neuronal Maintenance, $30,188; Hill, Joseph, NIH, STIM1: Master Regulator of Calcium Homeostasis in Cardiomyocytes, $389,550; Hofmann, Sandra, NIH, Role of DHHC Protein Palmitoyltransferases in Non-Small Cell Lung Cancer, $172,913; Hooper, Lora, NIH, Integrative Immunology Training Program, $369,743;

Hsieh, Jenny, NIH, Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts, $129,168; Hsieh, Jenny, Res Fdn for Mental Hygiene/NIH, Diverse Roles of Adult Dentate Gyrus Neurogenesis, $60,761; Huang, Hao, NIH, Structural Development of Human Fetal Brain, $358,886; Huang, Hao, NIH, Structural Development of Human Fetal Brain - Admin Suppl, $274,485; Huang, Jun-Shen, NIH, JAK2 Signaling in Erythropoiesis, $389,550; Huet, Beverley, Univ of North Texas Health Sci Ctr/NIH, Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease, $10,532; Idris, Ahamed, Mount Sinai School of Medicine/NIH, Community VOICES 3: Views On Informed Consent in Emergency Situations, $54,995; Igarashi, Peter, NIH, Regulation of Kidney-Specific Gene Expression, $345,825; Jain, Mamta, Virginai Commonwealth Univ/NIH, HBV/HIV Co-Infection Research Network, $44,633; Jia, Xun, NIH, Progressive Cone-Beam CT Dose Control Scheme for Image-Guided radiation Therapy, $172,913;

Jiang, Jin, NIH, Complex Regulation of Ci-Gli Proteins in Hedgehog Signal Transduction, $341,850; Jiang, Jin, NIH, Genetic Control of Drosophila Intestine Stem Cell Self-Renewal and Proliferation, $302,100; Johnson, Jane, NIH, Regulation and Function of Asc11 in Neural Development, $344,335; Johnson, Mark, Yale Univ/NIH, Insulin Resistance Intervention after Stroke (IRIS) Trial, $1,245; Journeycake, Janna, UT Health Science Ctr at Houston/CDC, Public Health Surveillance for Prevention of Complications of Bleeding and Clotting Disorders, $19,756; Journeycake, Janna, Blood Center of Wisconsin/NIH, Comparative Effectiveness in the Diagnosis of VWD, $5,988; Kavalali, Ege, NIH, Role of SNARE Interactions in Central Synapse Function, $397,500; Kavalali, Ege, NIH, Cellular Biophysics of Neuron Training Program, $126,838; Kitchell, Ellen, TX Dept of State Health Svc/CDC, HIV/PREVF HIV- Prevention Services Federally Funded, $200,800;

Knudsen, Erik, NIH, Action of RB Pathway in Breast Cancer Therapy, $310,426; Knudsen, Erik, NIH, Action of RB Pathway in Breast Cancer Therapy - Diversity Suppl, $66,726; Kramer, Helmut, NIH, Genetics of Endocytic Trafficking in Drosophila Eye, $25,440; Kraus, William, NIH, Role of PARP-1 in Hormone-Related Transcription, $411,774; Le, Lu, US Dept of Defense, Cell of Origin and Roles of Tumor Microenvironment in Dermal Neurofibroma Development and Therapeutics, $211,999; Levine, Benjamin, NIH, Aging, Fitness & Failure: Mechanisms of Diastolic Dysfunction, $556,770; Levine, Benjamin, NIH, Aging, Fitness & Failure: Mechanisms of Diastolic Dysfunction - Diversity Suppl, $83,457; Levine, Benjamin, Natl Space Biomedical Res Inst, Team Leader for Cardiovascular Alterations Team, $60,000; Levine, Beth, NIH, Infectious Diseases Training Program, $40,606; Li, Wen-Hong, NIH, Photonic Probe and Techniques for Biological Imaging Applications, $333,900;

Liu, Peiying, NIH, Quantification of Brain Metabolic Rate in Neonates Using MRI, $238,500; Liu, Zhi-Ping, NIH, Epigenetic Regulation of Cardiac Hypertrophy and Heart Failure, $389,550; Lotan, Yair, UT Arlington/NSF, Functionalized Nano-Textured Surfaces to Isolate and Identify Tumor Cells, $49,296; Lu, Hanzhang, NIH, Cognition and Cerebrovascular Function across the Lifespan, $257,611; Luo, Xuelian, NIH, Activation Mechanism of the Tumor-Suppressing MST-LATS Kinase Cascade, $302,100; Maher, Elizabeth, NIH, Defining Metabolic Phenotype of Low Grade Gliomas in Vivo, $320,027; Malter, James, Univ of Wisconsin/NIH, Role of Eosinophils in Airway Inflammation and Remodeling, $97,978; Mangelsdorf, David, NIH, Mechanisms of Drug Action and Disposition, $354,025; Martinez, Elisabeth, NIH, Characterization of Biological Activities of Novel Epigenetic Modulators, $22,402; Martinez, Elisabeth, NIH, Characterization of Biological Activities of Novel Epigenetic Modulators - Diversity Suppl, $9,572;

Mason, Ralph, NIH, Hypoxia and Radiotherapy: Evaluation and Mitigation in Tumors, $22,402; Mendell, Joshua, NIH, c-Myc-Regulated MicroRNAs in Normal and Pathologic Cellular Physiology, $284,246; Miller, David, Gynecological Oncology Group/NIH, Gynecologic Oncology Group Studies (Per Capita), $120; Mineo, Chieko, NIH, Discovery of Novel Interventions of Antiphospholipid Syndrome, $389,550; Minna, John (Fellow A. Augustyn), NIH, Defining Molecularly Distinct Subtype of Non Small Cell Lung Cancer, $29,726; Monteggia, Lisa, NIH, Antidepressants and Intracellular Signaling Linked to BDNF, $393,525; Mootha, Venkateswara, NIH, Genetics and Genomics of Fuchs Endothelial Corneal Dystrophy, $311,640; Mosconi, Matthew, NIH, Motor Control and Cerebellar Maturation in Autism, $157,148; Munshi, Nikhil, NIH, Molecular Dissection of Cardiac Conduction System Development, $130,040; Nedzi, Lucien, American College of Radiology/NIH, Radiation Therapy Oncology Group (RTOG); Agmt #5915, $38,500;

Niederkorn, Jerry, NIH, Immunological Modulation of Ocular Tumor Metastases, $19,752; Norgard, Michael, NIH, Molecular Microbiology Training Grant, $290,120; Norgard, Michael, NIH, Structure and Function of Treponema Pallidum Lipoproteins, $43,946; Norgard, Michael, NIH, RpoN-RpoS Regulatory Pathway in Borrellia Burgdorferi, $39,352; Olson, Eric, NIH, Heart Repair Through Reprogramming of Cardiac Cell Fate, $520,652; Olson, Eric, NIH, Metabolic Control by Myogenic MicroRNAs, Mediator and Myokines, $477,000; Olson, Eric (Fellow J. Papizan), NIH, The Role of DNA Methylation in Cardiac Regeneration, $51,530; Parada, Luis, NIH, Genetic Mouse Models of Glioma, $369,875; Pasare, Chandrashekhar, NIH, Toll-Like Receptor Mediated Regulation of Effector and Memory CD4 T Cell Responses, $393,525; Pascual, Juan, NIH, Modulation of Neural Function in Energy Failure, $344,335;

Patel, Vishal, NIH, miRNA-based Therapeutics in Polycystic Kidney Disease, $79,500; Pearson, Gray, NIH, Investigating Breast Cancer Collective Invasion, $23,094; Petroll, Matthew, NIH, Assessment of Corneal Fibroblast Biomechanical Behavior, $389,550; Pfeiffer, Julie, NIH, Enteric Virus-Microbiota Interactions, $420,757; Phillips, Margaret, NIH, Polyamine and Trypanothione Metabolism in Trypanosoma Brucei, $376,850; Phillips, Margaret, NIH, Lead Optimization of DHODH Inhibitors for Malaria, $59,544; Powell, Craig, NIH, Striatal Synaptic Abnormalities in Models of Autism, $397,500; Raj, Ganesh, Univ of Washington/US Dept of Defense, Targeting the Aberrant Androgen Receptor in Advanced Treatment Resistant Prostate Cancer, $473,098; Rakheja, Dinesh, Johns Hopkins Univ/NIH, Determining Roles of ATRX and DAXX Abnormalities in Cancer Telomere Biology, $12,009; Raskin, Philip, Tufts Univ/NIH, Vitamin D and Type 2 Diabetes (D2d Study), $11,925; Reese, Michael, NIH, Interrogating the Interaction of Toxoplasma Secreted Factors Host Imunne Reponse, $162,000;

Rice, Luke, NIH, Conformation and Recognition in Microtubule Dynamics, $302,100; Rizo-Rey, Jose, NIH, Neurotransmitter Release Machinery: Structure and Function, $454,896; Robertson, Danielle, NIH, Interactive Effects of OSA and T2DM on Corneal and Ocular Surface Disease, $238,500; Rodriguez-Baez, Norberto, Univ of Pittsburgh/NIH, Multi-Center Group to Study Acute Liver Failure in Children, $114,883; Rodriguez-Baez, Norberto, Univ of Pittsburgh/NIH, Multi-Center Group to Study Acute Liver Failure in Children - Per Patient, $24,000; Rohatgi, Anand, NIH, Moving Beyond HDL Cholesterol, HDL Function as a Coronary Disease Biomarker, $117,720; Rosenberg, Roger, Univ of Washington/NIH, National Alzheimer's Coordinating Center, $600; Ross, Elliott, NIH, G Protein-Coupled Receptors - Structure and Regulation, $39,750; Roth, Michael, NIH, Novel Inhibitors of Viral Replication, $401,322; Roth, Michael, NIH, Using Chemical Biology to Interfere with Influenza Virus Life Cycle, $393,525;

Rutherford, Cynthia, UT Health Sci Ctr at Houston/CDC, Public Health Surveillance for Prevention of Complications of Bleeding and Clotting Disorders, $17,088; Sakhaee, Khashayar, Office of Naval Res, Pathophysiologic Mechanism of Ammonium Urate Nephrolithiasis in Navy Dolphins, $194,596; Satterthwaite, Anne, Univ of Houston/NIH, Lupus Genes and B Cell Signaling, $35,370; Schaffer, Joseph, RTI Intl/NIH, NICHD Pelvic Floor Disorders Network - Capitation Funding, $3,121; Scherer, Philipp, NIH, White Adipose Tissue Physiology, Mitochondrial Function and Adiponectin, $464,280; Scherer, Philipp, NIH, ACRP, A Protein Secreted From Adipose Tissue, $432,393; Schiller, Joan, NIH, UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10, $648,000; Schmid, Sandra, NIH, Mechanisms Regulating Clathrin-Mediated Endocytosis, $417,068; Schneider, Jay, NIH, Microenvironmental Control of Progenitors in Organ Dysfunction and Repair, $1,171,517;

Shaul, Philip, NIH, Oxysterols, Estrogen Receptor Antagonism and Vascular Disease, $384,442; Shaul, Philip, NIH, Fc gramma RIIB and Inflammation-Related Vascular Disease, $350,595; Shaul, Philip, Univ of Cincinnati/NIH, Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation, $347,003; Sherry, Dean, NIH, Metabolism in the Heart by NMR, $389,550; Sherry, Dean, NIH, PARACEST Agents for Molecular Imaging of Cancer by MRI, $18,759; Sherry, Dean (Fellow C. Khemtong), US Dept of Defense, Hyperpolarized 15N Magnetic Resonance Imaging of Tumor Hypoxia in Prostate Cancer, $119,250; Shiloh, Michael, NIH, Identification of Novel M. Tuberculosis Secreted Effector Proteins, $19,534; Skinner, Celette, NIH, Parkland-UT Southwestern PROSPR Center: Colon Cancer Screening in Safety Net, $1,171,122; Snell, William, NIH, Cell Surface Recognition and Cell Interactions-Bridge Supplement, $125,968; Sperandio, Vanessa, NIH, Sugar Regulation of EHEC Virulence, $397,500; Sperandio, Vanessa, NIH, Quorum Sensing Regulation of EHEC Virulence Genes, $47,700;

Sternweis, Paul, NIH, Signal Transduction Via Receptors and G Proteins, $492,142; Stull, James, NIH, Signal Transduction Mechanisms to Myosin Phosphatase, $31,800; Takahashi, Joseph, NIH, Transcriptional Architecture and Chromatin Landscape of Circadian Clocks in Aging Tissue, $278,250; Takahashi, Joseph, UT Health Sci Ctr at Houston/NIH, Role of Clock-Modulating Small Molecules Against Aging, $47,700; Tambar, Uttam, NIH, Stereoselective Rearrangements for Synthesis of Bioactive Small Molecules, $310,050; Tamminga, Carol, NIH, Basic Science Training Program in Neurobiology of Mental Illness, $257,234; Tamminga, Carol, NIH, Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP), $237,881; Tamminga, Carol, Mount Sinai School of Medicine/NIH, Epigenetic Mechanisms of Depression, $53,263; Terada, Lance, NIH, Training Program in Lung Biology and Disease, $347,663;

Thomas, Philip, NIH, Development of Membrane Protein Structure, $364,266; Tiro, Jasmin, NIH, Developing a Self-Persuasion Intervention Promoting Adolescent HPV Vaccination, $405,638; Tiro, Jasmin, NIH, Developing a Self-Persuasion Intervention Promoting Adolescent HPV Vaccination - Diversity Suppl, $37,990; Toto, Robert, NIH, UT Southwestern Center for Translational Medicine - UL1, $5,317,736; Toto, Robert, NIH, UT Southwestern Center for Translational Medicine - KL2, $929,591; Tu, Benjamin (Fellow S. Kaochar), NIH, Temporal Dynamics of mRNP Granules in Relation to Cellular Metabolic State, $55,094; Van Buren, Peter, NIH, Mechanisms of Increased Ambulatory Blood Pressure in Intradialytic Hypertension, $144,612; van Oers, Nicolai (Fellow A. Hoover), NIH, The lnc to Clinical Abnormalities in 22q11_2 Deletion DiGeorge Syndrome, $30,188; Vongpatanasin, Wanpen, NIH, Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension, $44,079; Wan, Yihong, NIH, Connection of Mineral and Energy Metabolism by Nuclear Receptor PPAR-Gamma, $350,595;

Wang, David, NIH, Hedgehog Signaling in the Development of Barrett's Esophagus, $280,651; Wang, Junmei, Univ of California, Davis/NIH, Amber Force Field Consortium: a Coherent Biomolecular Simulation Platform, $107,708; Weakley, David, Emory Univ/NIH, Infant Aphakia Treatment Study (IATS), $10,319; White, Michael, NIH, Components of RAS Mediated Growth Control, $314,988; Whitehurst, Angelique, NIH, Mechanistic Elaboration of Fragility in the Cancer Cell Mitotic Spindle, $21,970; Whitworth, Louis, Johns Hopkins Univ/NIH, Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III (MISTIE III), $12,600; Winter, Sebastian, NIH, Nitrate Respiration by Salmonella During Gut Inflammation, $238,500; Wolf, Steven, Stratatech Corp/US Dept of Defense, Dose-Escal Study of Stratagraft Skin Tissue in Promoting Healing of Deep Partial-Thickness Component of Complex Skin Defects, $11,382; Wolf, Steven, American Burn Assn/US Dept of Defense ISIS: Development of Inhalation Injury Scoring System to Predict Severity of Inhalation Injury, $3,775;

Word, Ann, NIH, Elastic Fiber Homeostasis in the Vaginal Wall, $324,413; Wright, Woodring, NIH, Gene Expression in Aging and Development, $365,442; Wright, Woodring, NIH, Manipulating Telomerase Alternative Splicing for Cancer Therapy, $23,094; Wyckoff, Myra, RTI Intl/NIH, NICHD Neonatal Research Network Capitation Funding, $44,435; Xie, Yang, NIH, Predicting Adjuvant Chemotherapy Response in Lung Cancer, $26,614; Yamazaki, Shin, Natl Science Fdn, Exploring the Interaction Between Light- and Food-Entrainable Oscillators, $185,000; Yan, Nan, NIH, HIV Subversion of Innate Immunity, $39,750; Yanagisawa, Hiromi, NIH, Protease Regulation and Integrity of Connective Tissues of Pelvic Floor, $307,859; Yanagisawa, Hiromi, NIH, Loss of Matrix Regulation and Aortic Aneurysm Development in Vivo, $31,703; Yarovinsky, Felix, NIH, Cellular and Molecular Mechanisms of Host Resistance to Toxoplasma Gondii, $39,352;

Ye, Jin, NIH, Regulated Intramembrane Proteolysis of CREB3L1 in Innate Antiviral Response, $393,525; Yin, Helen, NIH, Mechanisms of Disease & Translational Science, $65,690; Zhang, Chengcheng, NIH, Role of Inhibitory Receptors in Leukemia Development, $23,094; Zhang, Chun-Li, NIH, In Vivo Reprogramming of Glial Fate for Spinal Cord Repair, $347,813; Zhang, Chun-Li, NIH, Transcriptional Control of Adult Neural Stem Cells, $344,335; Zhu, Hao, NIH, Metabolic Roles for Lin28-let-7 miRNA Pathway in Sarcoma Tumorigenesis, $161,460; Zigman, Jeffrey, NIH, Ghrelin's Role in Mood, $39,352; Zinn, Andrew, NIH, Medical Scientist Training Program at UTSW, $710,276.

Return to Top

Nonfederal Awards

Alto, Neal, CPRIT, Using Microbial Pathogens to Probe Weaknesses in Human Lung Cancer, $99,736; Alto, Neal, Welch Fdn, Post-Translational Modification of Host Enzymes by Bacterial Effector Proteins, $75,000; Altschuler, Steven, Welch Fdn, Mechanism and Zonation of Hepatic Crosstalk Between Lipogenesis and Canonical Wnt-Signaling, $60,000; Beutler, Bruce (Fellow E. Turer), Crohn’s & Colitis Fdn of America, Genetic Analysis of Gastrointestinal Inflammation Through ENU Mutagenesis, $58,250; Blount, Paul, CPRIT, Imaging Cancerous Tissues with Liposomal MRI Contrast Agents that Utilize Bioengineered Nanovalves, $409,726; Brugarolas, James, CPRIT, Evaluation of the Role of the BAP1 Tumor Suppressor Gene in Renal Cancer, $401,817; Brugarolas, James, CPRIT, Exploiting Synthetic Lethality, Drug Synergy, and an Animal Model Reproducing Drug Sensitivities in Humans to Identify Small Molecules to Treat Renal Cancer, $99,997;

Bruick, Richard, Welch Fdn, Analytical Approaches to Characterize Iron- and Oxygen-Sensing Mechanisms Governing Cellular Iron Homeostasis, $60,000; Burgess, Shawn, Welch Fdn, Dysregulation of Intracellular Lipid Synthesis During Disease, $60,000; Burstein, Ezra, CPRIT, COMMD1 and the Control of Tumor Invasion, $263,091; Castro, Diana, GBS-CIDP Fdn Intl, International GBS Outcomes Study (IGOS), $10,000; Chen, Zhijian, Welch Fdn, Biochemical Mechanism of MAVS Activation by Prion-Like Polymerization, $100,000; Chiang, Cheng-Ming, Welch Fdn, Mechanistic Action of BET Compound Inhibitors in Cancer Therapeutics, $60,000; Choi, Changho, CPRIT, Clinical MR Spectroscopy Development of 2-Hydroxyglutarate as a Specific Biomarker for Malignant Gliomas, $334,708; Choi, Changho, CPRIT, High Field MRS and CEST Imaging of Brain Tumors: Biomarkers of Therapeutic Response: P4, $65,353; Chuang, David, Welch Fdn, Mitochondrial Signaling by Reversible Phosphorylation, $60,000;

Cleaver, Ondine (Fellow C. Braitsch), Juvenile Diabetes Res Fdn, YAP/TAZ in Pancreas Epithelial Stratification and Progenitor Cell Fate, $46,864; Cobb, Melanie, CPRIT, Coordination of Inputs from Taste Receptors and Ras/ERK1/2 Axis to mTORC1: Mechanisms and Pathway Interactions in Cancer, $405,000; Conrad, Nicholas, American Cancer SocC, Posttranscriptional Regulation of Metabolic Genes Involved in Cancer, $198,000; Conrad, Nicholas, Welch Fdn, Biochemical Analysis of a Nuclear Poly(A)-Dependent RNA Decay Pathway, $60,000; Cowell, Lindsay, Univ of Kansas Medical Cntr/PCORI, Greater Plains Collaborative Clinical Data Research Network Phase I, $179,720; Crandall, Craig, Natl Multiple Sclerosis Soc, Heat Exposure and Posture Stability in MS Patients, $43,966; Deberardinis, Ralph, CPRIT, The Metabolic Phenome of Human Lung Cancer, $223,585; Deberardinis, Ralph, Welch Fdn, Glutamine-Dependent Reductive Carboxylation: a Metabolic Achilles Heel in Cancer, $100,000;

DeMartino, George, Welch Fdn, Regulation of Proteasome Function by Reversible SUMOylation, $60,000; D'Orso, Ivan, Welch Fdn, Cooperative Assembly of HIV Transcription Elongation Complexes, $60,000; Elmquist, Joel, Klarman Family Fdn, Hypothalamic Htr2c Circuits and the Regulation of Feeding and Emotional Behaviors, $200,000; Elmquist, Joel (Fellow T. Liu), American Heart Assn Natl, Autonomic Regulation of Adipocyte Metabolism by Melanocortin-4 Receptors, $77,000; Frohman, Elliot, New York Univ/NMSS, Mechanisms of Retinal Neurodegeneration and Visual Pathway Axonal Loss in MS, $48,038; Gao, Jinming, CPRIT, Beta-Lapachone Nanotherapeutics for NQO1-Targeted Therapy of Cancer, $340,593; Gardner, Kevin, CPRIT, Discovery and Optimization of Natural and Artificial Ligands Regulating Hypoxia Inducible Factor, $475,894; Gardner, Kevin, CPRIT, Development of Optogenetic Tools for Cellular and In Vivo Manipulation of Cancer Pathways, $99,894;

Gazdar, Adi, Uniting Against Lung Cancer, Development of Targeted Therapy for SMARCA4 Mutant Containing Non Small Cell Lung Cancers, $100,000; Giesecke, Noel, Fdn for Anesthesia Educ and Rsrch, UTSW Anesthesia FAER Summer Fellowship, $6,200; Girard, Luc, Ohio State Univ/Lungevity Fdn, Biomarkers for Personalizing Adjuvant Therapy in NSCLC - Increasing Cures, $100,000; Goldsmith, Elizabeth, Welch Fdn, Docking Interactions Between MAP3Ks, ASK1/TAO2 and B-Raf with Their Cognate MAP2Ks MEK6 and MK1, $75,000; Grishin, Nick, Citrus Res and Development Fdn, Molecular basis of Citrus Greening and Related Diseases Gleaned from Genome Analyses of Hosts and Pathogens, $100,000; Grishin, Nick, Welch Fdn, Structure Mechanism of Circadian Clock-Mediated Transcription Activation, $75,000; Gul, Fatma (Fellow L. Babajide), Fdn of the CMSC, FCMSC Student Research Scholarship 2014, $5,000;

Hibbs, Ryan, Welch Fdn, Structural Basis of Chemical Transmitter Recognition by Pentameric Ligand-Gated Ion Channels, $60,000; Hiesinger, Robin, Welch Fdn, Role of V0 ATPase in SNARE-Mediated Membrane Fusion, $60,000; Hill, Joseph, American Heart Assn Natl, UT Southwestern Medical Center Strategically Focused Prevention Research Center, $899,800; Hobbs, Helen (Fellow R. Shah), Howard Hughes Medical Inst, 2014 HHMI Medical Research Fellow, $40,000; Holland, William, Juvenile Diabetes Res Fdn, Sphingosine Kinases in Beta Cell Survival and Proliferation, $150,000; Hooper, Lora, CPRIT, Engineering Membrane Toxic C-Type Lectins for Tumor Targeting, $100,000; Hrycushko, Brian, Radiological Soc of North America, Local Hypothermia as a Radioprotector during Prostate Stereotactic Body Radiotherapy, $39,987; Hsieh, Jenny, Welch Fdn, Chemical Regulation of Adult Hippocampal Neurogenesis and Memory, $75,000;

Igarashi, Peter, Intl Soc of Nephrology, Sister Renal Center Nigeria-USA2--(Category C), $1,500; Igarashi, Peter (Fellow S. Ferre), American Soc of Nephrology, Understanding the Regulation of HNF-1beta Expression by ER Stress Effectors, $50,000; Jain, Raksha, Cystic Fivrosis Fdn, One CF Center: Learning and Leadership Collaborative, $11,880; Jiang, Youxing, Welch Fdn, Structural and Functional Studies of RCK-Regulated Potassium Channel, $100,000; Johnson, Jane, CPRIT, Requirement for Ascl1 in Gliomagenesis, $249,046; Kelly, Nancy, American Academy of Pediatrics, AAP 2014-15 Healthy Active Living Grant: Supporting Healthy Families, $18,098; Kim, Taekyung, Welch Fdn, Biochemical Characterization of Novel Class of Noncoding RNAs, $60,000; Kliewer, Steven, Welch Fdn, Characterization of Endogenous Ligand for Immunomodulatory Orphan Nuclear Receptor ROR, $100,000; Kraus, William, CPRIT, Role of Long Non-Coding RNAs in Breast Cancers: Identification, Characterization, and Determination of Molecular Functions, $302,855;

Le, Lu (Fellow C. Liao), Children’s Tumor Fdn, Tumor Microenvironment and Stem Cell Factor Contributions in Neurofibroma Development, $51,500; Lee, Michael, Fdn for Surgical Fellowships, Bariatric/MIS Fellowship, $35,000; Levine, Benjamin, Partnership for Clean Competition, Safety, Efficacy and Detection of Xenon Supplementation for Increased Red Cell Mass in Highly Trained Athletes, $128,098; Li, Bing, Welch Fdn, Biochemical and Functional Analysis of Histone Clipping, $60,000; Li, Wen-Hong, Juvenile Diabetes Res Fdn, Biomarkers of Functional Beta Cells, $275,000; Liou, Jen, Welch Fdn, Novel Imaging Probes for Investigating ER-Plasma Membrane Junctions, $60,000; Liu, Xin, Welch Fdn, Structural and Biochemical Studies of Gene Repression by Polycomb Repressive Complex 2: Catalysis and Recruitment, $60,000; Liu, Yi, Welch Fdn, Biochemical Mechanisms of Small RNA Production Pathways, $100,000;

Lum, Lawrence, CPRIT, Molecularly Targeted Anticancer Therapeutic Strategy Premised upon Attack of Aberrant Wnt Pathway Responses, $463,208; Lum, Lawrence, Welch Fdn, Modulation of Canonical Wnt Pathway Activity Using Small Molecules, $75,000; Mahendroo, Mala, Burroughs Wellcome Fund, Dynamic Architecture of Cervical Collagen by SHG Endoscopy, $150,000; Maher, Elizabeth, CPRIT, Genotype and Metabolic Phenotype in Pediatric Brain Cancer, $350,000; Malloy, Craig, CPRIT, Biomarkers and Metabolic Pathways in Gliomas: P2, $52,876; Mangelsdorf, David, Welch Fdn, Ligand Binding Properties of Nematode Orphan Nuclear Receptors, $100,000; Merritt, Matthew, CPRIT, Metobolic Imaging of Hyperpolarized 13C Substrates in Animal Models of Cancer: P3, $52,595; Moe, Orson (Fellow J. Neyra Lozano), American Soc of Nephrology, Klotho and Acute Kidney Injury: A Case-Control Study in Humans, $50,000; Morrison, Sean (Fellow E. Piskounova), Helen Hay Whitney Fdn, Role of Lyn Kinase on Melanoma Metastasis, $50,500;

Nam, Yunsun, Pew Scholars Program, Mechanism and Regulation of microRNA processing by Microprocessor, $60,000; Nguyen, Benjamin (Fellow J. Watkins), Allergan Pharmaceuticals, Allergan Fellow Grant, $25,000; Nguyen, Benjamin (Fellow J. Watkins), Medtronic Neuromodulation, Medtronic Spasticity Fellowship FY 2014, $25,000; Nguyen, Benjamin (Fellow J. Watkins), Solstice Neurosciences, Solstice Brain Injury Fellowship 2014, $5,000; Noe, Carl, Boston Scientific Neuromodulation, UT Southwestern Medical Center Pain Medicine Fellowship, $88,742; Orth, Kim, Welch Fdn, Elucidate Biochemical Mechanism Used by Vibrio VopQ to Induce Autophagy, $100,000; Parada, Luis, Johns Hopkins Univ, Primary Plexiform Neurofibroma Cell Culture Model for Use in Cell-Based High Throughput Screens, $165,000; Pasare, Chandrashekhar, Welch Fdn, Biochemical Role of IRAK-1 in Regulating Caspase-1 Activation and Cleavage, $60,000;

Peshock, Ronald (Fellow C. Maroules), Radiological Soc of North America, Quantification of Volumetric Pulmonary Perfusion Using 3D Arterial Spin Labeled Perfusion MRI, $30,000; Potts, Ryan, Welch Fdn, Therapeutic Targeting of Melanoma Antigen (MAGE) Genes, $60,000; Radhakrishnan, Arun, Welch Fdn, Fluorescent Sensors for Measuring Cholesterol in Live Cells, $60,000; Ranganathan, Rama, Welch Fdn, Structural Principles of Protein Robustness and Evolvability, $100,000; Rizo-Rey, Jose, Welch Fdn, NMR Methods to Study Membrane Proteins in Lipid Bilayers, $75,000; Sathe, Meghana, Cystic Fibrosis Fdn, Developing Innovative GastroEnterology Speciality Training, $32,290; Schmid, Sandra, Welch Fdn, Conformational Dynamics and Regulation of Dynamin, $60,000; Schmid, Sandra (Fellow J. Mattila), Academy of Finland, GTP-Driven Conformational Changes and Their Role in Dynamin-Catalyzed Membrane Fission, $18,341;

Shay, Jerry, CPRIT, Development of Therapeutics Targeting Truncated Adenomatous Polyposis Coli (APC) as Novel Prevention and Intervention Strategy for Colorectal Cancer, $200,000; Sherry, Dean, CPRIT, Novel MRI and MRS Methods for Imaging Cancer Metabolism: Admin, $7,602; Story, Michael, CPRIT, P1: Enhancing Identification of Markers and Potential Therapeutic Targets for Improving Tumor Response via MIRNA and DNA Methylation Analysis, $291,503; Sun, Xiankai, UT Dallas/CPRIT, Targeting Tumor Microenvironment for Cancer Imaging and Therapy: Renal Clearable and pH Responsive Gold Nanoparticles, $186,290; Tambar, Uttam, Welch Fdn, Stereoselective Allylic Functionalization of Olefins, $60,000; Tamminga, Carol, Autism Speaks, Node for Autism BrainNet, $188,222; Taurog, Joel, Spondylitis Assn of America, Effect of Mutations in ERAP1 on Spondyloarthritis in HLA-B27 Transgenic Rats, $50,001; Terman, Jonathan, Welch Fdn, Chemistry and Enzymology of MICAL Family Oxidoreductases, $75,000;

Tu, Benjamin, Welch Fdn, Selective Regulation of Autophagy by Metabolic State, $60,000; Turley, Stephen, Rett Syndrome Res Trust, Brain Cholesterol Metabolism in a Mouse Model for Rett Syndrome: Exploratory Study, $20,000; Udugamasooriya, Damith, CPRIT, Tumor Cell Lytic Peptoids that Target Exposed Phosphatidylserine, $268,387; Uyeda, Kosaku, Welch Fdn, Biochemical Mechanism of Glucose Sensing and Regulation of ChREBP Activity, $60,000; Wan, Yihong, CPRIT, Osteoclast Regulation of Bone Metastis of Cancer, $363,824; Wan, Yihong, March of Dimes Fdn, Maternal VLDLR Regulation of Milk PAFAH and Neonatal Inflammation, $126,673; Wan, Yihong, Welch Fdn, Biochemical Characterization of PAFAH Regulation by Macrophage VLDLR, $75,000; Wang, Jing, CPRIT, Quantitative Cone-beam CT for Adaptive Radiation Therapy, $214,634; Wang, Zhigao, Welch Fdn, Biochemical Identification of Proteases Involved in Necrotic Cell Death Execution, $60,000;

Westover, Kenneth, Welch Fdn, Characterization of Covalent K-Ras Inhibitors, $60,000; White, Michael, Welch Fdn, Analysis of Functional Significance of Complex Protein/Protein Interactions, $100,000; Wolf, Matthias, American Soc of Nephrology, The Role of Mucin 1 in Protection Against Nephrolithiasis by Regulation of the Renal Calcium Channel TRPV5, $100,000; Wu, Jiang, March of Dimes Birth Defects Fdn, Decoding Chromatin Regulation of Sonic Hedgehog Signaling with Proteomic Approaches, $110,166; Wu, Lani, Welch Fdn, On Evolution of Drug-Resistant Lung Cancer Subpopulations, $75,000; Yan, Nan, Welch Fdn, Tail-Anchor of a Critical Innate Immunity Regulator TREX1 on the ER, $60,000; Yarovinsky, Felix, Welch Fdn, Structural Basis of Parasite Recognition by TLR11 and TLR12 Receptors, $60,000;

Ye, Jin, Welch Fdn, Saturated Fatty Acid-Induced Lipotoxicity, $60,000; Yu, Yonghao, Welch Fdn, Large-Scale Isolation and Identification of Poly-ADP-Ribosylated Proteins, $60,000; Zhang, Chengcheng, March of Dimes Fdn, Angptl Receptor Supported Expansion of Cord Blood Stem Cells, $107,225; Zhang, Chengcheng, Welch Fdn, Small Molecule Modulators of Angptl Receptor for Stem Cell Expansion and Leukemia Treatment, $60,000; Zhang, Chun-Li, Welch Fdn, Regulation of Orphan Nuclear Receptor TLX by Small Molecules, $60,000; Zhang, Rong (Fellow T. Tarumi), American Heart Assn SW, PostDoc Arterial Stiffness, Intracranial Hemodynamics and Leukoaraiosis, $46,364.

Return to Top

Industry Sponsored Awards, dollar amounts not available

Anderson, Larry, Phase 1/2b Study of Bruton's Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) in Comb with Carfilzomib (Kyprolis) in Sbjs with Multiple Myeloma, Pharmacyclics Inc; Anderson, Larry, Phase 3 Study of Conventional Dose Treatment (RVD) to High-Dose Treatment in Management of Myeloma in Pts up to 65 Yrs (IFM/DFCI 2009), Dana-farber Cancer Inst; Arriaga, Yull, Phase 3 Study of Adjuvant Regorafenib vs. Placebo for Pts with Stage IV Colorectal Cancer after Curative Treatment of Liver Metastases, Covance Inc; Beutler, Bruce, Genetic Studies of IBD and Autoimmunity, Daiichi Sankyo; Bowers, Daniel, Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma (SJMB12), St. Jude Children’s Hosp; Byerly, Matthew, Phase 4 Study Comparing Aripiprazole and Oral Antipsychotics in Non-adherent Outpatients with Schizophernia, Otsuka America Pharm Inc; Chin, Kelly, Study of Ambrisentan in Sbjs with Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH), GlaxoSmithKline;

Collins, Robert, Phase 3 Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Sbjs with FLT3-ITD Positive AML, Greenphire Inc; Courtney, Kevin, Enzalutamide and Gonadotropin-releasing hormone (GnRH) agonist before, during and after radiation therapy in treatment with high-risk localized prostate cancer, Astellas Pharma US Inc; Cripps, Michael, Angel Catheter Early Feasibility Clinical Study, Bio2 Medical Inc; De Lemos, James, Ancillary Biomarker Measurements in Dallas Heart Study, Abbott Labs; Drazner, Mark, Guiding Evidence Based Therapy Using Biomarker Intensified Treatment, Duke University; Gerber, David, Extension Protocol for Sbjs Previously Enrolled in Other Tivantinib (ARQ 197) Protocols, Arqule Inc; Gerber, David, Phase 3 Trial of Nivolumab vs. Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer, Bristol-Myers Squibb Co; Greenberg, David, Antibacterial PPMO Development, Sarepta Therapeutics;

Haley, Barbara, PrECOG 0102 - Phase 2 Trial of Fulvestrant (Faslodex) Plus Everolimus in Post-Menopausal Pts with Hormone-Receptor Positive Metastatic Breast Cancer Resistant to Aromatase Inhibitor, Alpha Oncology Inc; Iannaccone, Susan, Study of ISIS 396443 in Pts with Spinal Muscular Atrophy who Previously Participated in ISIS 396443-CS2 or ISIS 396443-CS10, Isis Pharm Inc; Jain, Raksha, Phase 2 Study of Aerovanc for Treatment of Persistent Methicillin-Resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Pts, Synteract Inc; Joglar, Jose, ST Monitoring to Detect ACS Events in ICD Patients Study, St. Jude Medical Iesd; Lavery, Lawrence, Study of INTEGRA skin sheet bilayer or single layer products used in complex lower extremity soft tissue reconstruction, Integra Lifesciences Corp; Lee, William, Phase II/III Study of MK-5172 and MK-8742 in Sbjs with Chronic Hepatitis C Virus Infection and Chronic Kidney Disease, Merck Sharp & Dohme Corp;

Lingvay, Ildiko, Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Sbjs with Type 2 Diabetes at High Risk of Cardiovascular Events, Novo Nordosk Inc; Lingvay, Ildiko, Comparison of Insulin Degludec/Liraglutide vs. Insulin Glargine in Sbjs with Type 2 Diabetes Mellitus, Novo Nordisk Inc; Lotan, Yair, Analyses of Plasma and Serum in Prostrate Cancer Patient, Metabolon Inc; Lotan, Yair, Eval of UroVysion Test in Predicting Recurrence and/or Progression of Disease in Pts Receiving Initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder, Abbott Molecular Inc;

Maher, Elizabeth, Phase 1 Study of Orally Admin AG-120 in Sbjs with Advanced Solid Tumors, including Glioma, with an IDH1 Mutation, Novella Clinical; Mansour, John, Phase 3 Study of Adjuvant Regorafenib vs. Placebo for Pts with Stage IV Colorectal Cancer after Curative Treatment of Liver Metastases, Covance Inc; Mayo, Marlyn, Phase 2 Study of NGM282 with Ursodeoxycholic Acid (UDCA) in Pts with Primary Biliary Cirrhosis, NGM Biopharm Australia Pty Ltd;

Naina, Harris, Phase 2 Study of IPI-145 in Sbjs with Refractory Indolent Non-Hodgkin Lymphoma, Clinical Financial Svcs; Raj, Ganesh, Targeted Disruption of androgen receptor & cofactors, Janssen Res & Dev LLC; Raskin, Philip, Phase 2 Study of Oral GKT137831 in Pts with Type 2 Diabetes and Albuminuria (GSN000200), Icon Clinical Res Inc; Roland, Peter, Evaluation of Lateral Wall Electrode in Temporal Bones, Advanced Bionics; Scherer, Philipp, Discovery and Characterization of novel anti-edotropin monoclonal antibodies as drug leads for cancer therapy, Panamab Inc; Schiller, Joan, ETP of Oral LDK378 in Adult Pts with Non-Small Cell Lung Cancer with ALK(+) Rearrangements in Pts Prev. Treated with ALK inhibitor, Novartis Pharm Corp; Schiller, Joan, Phase 1 Study of J&J 42756493, Pan-FGFR Tyrosine Kinase Inhibitor in Sbjs with Advanced or Refractory Solid Tumors or Lymphomas, Janssen Res & Dev LLC; Schiller, Joan, Phase 3 Trial of Tecemotide vs. Placebo in Sbjs with Completed Concurrent Chemo-Radiotherapy for Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC), Quintiles Inc;

Sutphin, Patrick, Observational Study of Tissue Plasminogen Activator Used for Catheter Directed Thrombolysis in Pts with Acute Lower Extremity Native Artery or Bypass Graft Occlusion, GRIFOLS THERAPEUTICS INC; Thomas, Philip, Identify Small Molecules that Inhibit Misfolding of Certain Disease-Related Proteins, REATA PHARM INC; Timaran, Carlos, Study of Zenith Branch Endovascular Graft-Iliac Bifurcation, MED INST INC; Torres, Fernando, Study of Bardoxolene Methyl in Pts with Pulmonary Arterial Hypertension, REATA PHARM INC; Toto, Robert, Phase 2 Study of AZD1722 in CKD Pts with Type 2 Diabetes Mellitus and Albuminuria, ARDELYX, INC; Trivedi, Jaya, Extension Study of Repeated Biweekly Infusions of neoGAA in Pts with Pompe Disease, GENZYME CORP; Unger, Roger, REMD 477 in Type 1 Diabetes, REMD BIOTHERAPEUTICS; Verma, Udit, Phase 3 Study of Gemcitabine with TH302 in Pts with Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma, COVANCE INC; Vernino, Steven, PHOENIX: Study of Pts with Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy, CLINVERSE INC;

Vusirikala, Madhuri, Phase 3 Study of CMX001 for Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients, PRA INTL; Winick, Naomi, Phase 2 Pilot Trial of Bortezomib in Comb with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma, CHILDREN'S HOSP OF PHILADELPHIA; Winick, Naomi, Phase 2 Study of MMLN8237 (IND#102984), a Selective Aurora A Kinase Inhibitor in Children with Recurrent/Refractory Solid Tumors and Leukemias, CHILDREN'S HOSP OF PHILADELPHIA; Winick, Naomi, Phase 3 Trial for Pts with de novo AML using Bortezomib and Sorafenib for Pts with Hugh Allelic Ratio FLT2/ITD, CHILDREN'S HOSP OF PHILADELPHIA; Wolf, Steven, BVS857 in Severe Burn with Hypercatabolic Status Sbjs, NOVARTIS PHARM CORP; Wu, Richard, Study of Rivaroxaban and Vitamin K Antagonists in Sbjs Undergoing Catheter Ablation for Atrial Fibrillation, JANSSEN SCIENTIFIC AFFAIRS LLC.

Return to Top

Share: